Tag: NASDAQ: OCGN

Business

Ocugen Inc (NASDAQ: OCGN) Obtains Producing Collaboration for U.S. Manufacture of COVID-19 Vaccine Entrant, COVAXIN™

Ocugen Inc (NASDAQ: OCGN), a biopharmaceutical business absorbed on discerning, evolving, and commercializing gene treatments to cure and mounting a vaccine to save exists from COVID-19, today proclaimed that it had nominated Jubilant HollisterStier of Spokane, Washington as its assembling companion for COVAXIN™ to concoct for potentially viable assembling of […]

Business

Law Firms Investigates Curis, Inc (NASDAQ: CRIS), Washington Prime Group Inc (NYSE: WPG), Array Technologies Inc (NASDAQ: ARRY), And Ocugen For Misleading Shareholders

Prominent law firms issues an alert to the shareholders of companies such as Washington Prime Group Inc (NYSE: WPG), Curis, Inc (NASDAQ: CRIS), Ocugen Inc (NASDAQ: OCGN), and Array Technologies Inc (NASDAQ: ARRY).  According to the class action lawsuits pending against these companies, the law firms seek investigations for misleading […]

Business

Ocugen Inc. (NASDAQ: OCGN) Will Not Submit EUA for COVAXIN as Indicated Earlier, Shares Plunge

Ocugen Inc. (NASDAQ: OCGN) dropped 24% in intraday trading on June 14, 2021, after national shareholder rights litigation firm, The Schall Law Firm announced that it is probing securities laws violation claims on behalf of Ocugen investors.  Block & Leviton is also investigating the same matter, and investors that lost […]

Business

Bharat Biotech Agrees To Expand Ocugen Inc (NASDAQ: OCGN)’s Covaxin Vaccine Commercialization Rights To Canada

Bharat Biotech and Ocugen Inc (NASDAQ: OCGN) have agreed to expand the existing Covaxin vaccine commercialization to include other nations.  As per the terms of the amended agreement, Ocugen received permission to sell Covaxin vaccines in Canada besides the existing rights in the US.  Ocugen’s CEO, Shankar Musunuri, said the […]